Sathgen completes dosing of first two cohorts of healthy volunteers with MSP008-22, a novel…
The clinical development of this drug is supported and managed by Clinexel Life Sciences
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
DCTs enable greater patient engagement through remote visits, eConsent, and patient-centric…
Gaurav Gupta, VP – Engineering at GlobalLogic, speaks about the evolution of Decentralised Clinical Trials (DCTs), its expanding…
Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe
Pharmazz India obtained marketing authorization for the management of Hypovolemic shock Lyfaquin (INN: Centhaquine) in India in…
OCTAVE study reveals vaccine response in patients with impaired immune systems
Preliminary data from the OCTAVE study in August 2021 showed that a significant proportion of clinically at-risk patients with…
Transgender inclusion in healthcare: Breaking barriers and creating equitable clinical trials
Jahanara Nayar Rahuldev, Diversity Equity Inclusion India Lead, Parexel accentuates that diversity, equity and inclusion in…
Advancing research on human immune systems in India to develop better vaccines
Dr Rama Akondy, Associate Professor of Biology, Ashoka University highlights that by fostering clinical and research partnerships,…
IIT Kanpur signs MOA with Laurus Labs for novel gene therapy assets
IIT Kanpur will transfer several gene therapy assets through in-licensing to Laurus Labs, who will provide a research grant to…
Dundee University gets £4.4 mn to advance gene ‘video editing’ for cancer and neurodegenerative…
The information in human genes is ‘split’, which allows a single gene to code for multiple proteins. If scientists can learn how…
Zydus announces Phase IV EVIDENCES-XI trial to generate RWE of Saroglitazar Mg in NAFLD patients…
Phase IV EVIDENCES- XI trial will enroll approximately 1500 NAFLD patients with comorbidities
Israeli researchers develop bio-sensing technology to predict cancer treatment response
The technology enables the screening of substantial amounts of cancer samples without requiring fresh biopsies or biological…
Dr Reddy’s completes Phase I study of DRL_TC, a tocilizumab biosimilar candidate
This Phase I study used an intravenous (IV) formulation to evaluate the pharmacokinetic equivalence, safety and immunogenicity of…
IIT Kanpur researchers visualise communication of G-protein coupled receptors, pave way for drug…
It visualises the cross talk between G protein-coupled receptors (GPCRs) involved in regulating heart function, blood pressure,…
Rakuten Medical to start phase 3 trial of Alluminox treatment using ASP-1929 for head and neck…
This ASP-1929-301 study is currently underway in several countries such as the US and Taiwan, and will enroll 275 patients…
Termination of Ultragenyx’s UX053 Phase I/II study is a minor setback for mRNA therapeutics:…
UX053 was one of five non-vaccine mRNA therapeutics in clinical trial development. The other four are all currently in Phase I/II…
Stempeutics concludes patient enrollment for Phase 3 cell therapy trial for diabetic foot ulcer
Cipla has in-licensed Stempeucel-DFU product for Sales & Marketing in India
Cloud enhancing data sets for real-world clinical trials
Shivajyoti Bhattacharjee, VP – Healthcare & Life Sciences, Cybage Software highlights how RWD and RWE are pivotal to clinical…
Brain cells are starved of energy when autophagy malfunctions: Study
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
How will green chemistry transform the future of pharma manufacturing
Implementing green chemistry in pharma manufacturing can reduce waste and pollution, improve efficiency, and promote…
Dundee University research find ADHD medication, Methylphenidate safe for long term treatment of…
WHO had rejected Methylphenidate for inclusion in their Essential Medicines List due to concerns regarding the quality and…
Synthetic lipids: Paving the path for better drug delivery systems
Arun Kedia, MD, VAV Lipids informs that as seen in the new mRNA-based COVID-19 vaccine delivery systems, synthetic lipid…